Russell Investments Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
34,015
+4,441
| +15% | +$1.34M | 0.01% | 840 |
|
|
2025
Q1 | $9.8M | Buy |
29,574
+28,092
| +1,896% | +$9.31M | 0.01% | 835 |
|
|
2024
Q4 | $457K | Buy |
1,482
+809
| +120% | +$250K | ﹤0.01% | 2297 |
|
|
2024
Q3 | $143K | Sell |
673
-8,629
| -93% | -$1.83M | ﹤0.01% | 2580 |
|
|
2024
Q2 | $2.61M | Buy |
9,302
+3,814
| +69% | +$1.07M | ﹤0.01% | 1504 |
|
|
2024
Q1 | $1.47M | Buy |
+5,488
| New | +$1.47M | ﹤0.01% | 1814 |
|
|
2023
Q4 | – | Sell |
-5
| Closed | -$730 | – | 3269 |
|
|
2023
Q3 | $730 | Sell |
5
-120
| -96% | -$17.5K | ﹤0.01% | 3368 |
|
|
2023
Q2 | $28.9K | Sell |
125
-100
| -44% | -$23.1K | ﹤0.01% | 2788 |
|
|
2023
Q1 | $54.5K | Buy |
+225
| New | +$54.5K | ﹤0.01% | 2702 |
|
|
2019
Q3 | – | Sell |
-15,313
| Closed | -$1.6M | – | 3065 |
|
|
2019
Q2 | $1.6M | Buy |
15,313
+10,868
| +244% | +$1.14M | ﹤0.01% | 1777 |
|
|
2019
Q1 | $557K | Buy |
+4,445
| New | +$557K | ﹤0.01% | 2306 |
|